Following the common cold, otitis media (OM), or inflammation of the middle ear, is the most frequent illness resulting in visits to physicians and the most common cause of hearing impairment in children. During the past few decades, an alarming increase in antibiotic resistance has been observed worldwide in bacteria that cause OM. Yet to date, no other therapies have been developed to combat this disease. Thus, there is an urgent need to develop new and innovative non-antibiotic approaches to prevent and manage OM. To this end, it is imperative to understand the molecular mechanisms that control the expression of innate immune molecules that comprise the tubotympanum's first line of defense against invading pathogens and determine if these mechanisms can be exploited to prevent or treat OM. Of the innate immune molecules tested to date, beta-defensin 2 is the most effective antimicrobial against the OM pathogens. Little however, is known about the molecular mechanisms that regulate the expression of this molecule by NTHi. Our hypothesis is that NTHi up-regulates beta-defensin 2 via activation of specific signaling pathways in middle ear epithelial cells. This is in line with our long-term objective to study the expression of well-characterized antimicrobial innate immune molecules and elucidate their role in OM pathogenesis. Towards our objective, we will 1) Identify the epithelial surface receptors and the receptor-associated adaptor components required for NTHi-induced p-defensin 2 up-regulation in vitro and in vivo, 2) Determine if the the MKK3/6-p38a/beta signaling pathway is involved in mediating NTHi-induced (3-defensin 2 upregulation in vitro and in vivo, and 3) Demonstrate that NTHi and IL-1alpha can synergistically up-regulate the expression of beta-defensin 2, via distinct signaling pathways. By discovering the signaling pathways that regulate beta-defensin 2 expression by NTHi, we may be able to identify molecular targets that could be used to boost the expression of this molecule to therapeutic levels in the tubotympanum.

Agency
National Institute of Health (NIH)
Institute
National Institute on Deafness and Other Communication Disorders (NIDCD)
Type
Research Project (R01)
Project #
5R01DC005025-06
Application #
7269452
Study Section
Auditory System Study Section (AUD)
Program Officer
Watson, Bracie
Project Start
2001-09-10
Project End
2009-06-30
Budget Start
2007-09-01
Budget End
2009-06-30
Support Year
6
Fiscal Year
2007
Total Cost
$322,381
Indirect Cost
Name
House Research Institute
Department
Type
DUNS #
062076989
City
Los Angeles
State
CA
Country
United States
Zip Code
90057
Woo, Jeong-Im; Kil, Sung-Hee; Brough, Douglas E et al. (2015) Therapeutic potential of adenovirus-mediated delivery of ?-defensin 2 for experimental otitis media. Innate Immun 21:215-24
Woo, Jeong-Im; Kil, Sung-Hee; Oh, Sejo et al. (2015) IL-10/HMOX1 signaling modulates cochlear inflammation via negative regulation of MCP-1/CCL2 expression in cochlear fibrocytes. J Immunol 194:3953-61
Woo, Jeong-Im; Oh, Sejo; Webster, Paul et al. (2014) NOD2/RICK-dependent ?-defensin 2 regulation is protective for nontypeable Haemophilus influenzae-induced middle ear infection. PLoS One 9:e90933
Woo, Jeong-Im; Kil, Sung-Hee; Pan, Huiqi et al. (2014) Distal NF-kB binding motif functions as an enhancer for nontypeable H. influenzae-induced DEFB4 regulation in epithelial cells. Biochem Biophys Res Commun 443:1035-40
Li, Jian-Dong; Hermansson, Ann; Ryan, Allen F et al. (2013) Panel 4: Recent advances in otitis media in molecular biology, biochemistry, genetics, and animal models. Otolaryngol Head Neck Surg 148:E52-63
Oh, Sejo; Woo, Jeong-Im; Lim, David J et al. (2012) ERK2-dependent activation of c-Jun is required for nontypeable Haemophilus influenzae-induced CXCL2 upregulation in inner ear fibrocytes. J Immunol 188:3496-505
Lim, David J; Moon, Sung K (2011) Establishment of cell lines from the human middle and inner ear epithelial cells. Adv Exp Med Biol 720:15-25
Woo, Jeong-Im; Pan, Huiqi; Oh, Sejo et al. (2010) Spiral ligament fibrocyte-derived MCP-1/CCL2 contributes to inner ear inflammation secondary to nontypeable H. influenzae-induced otitis media. BMC Infect Dis 10:314
Shimada, Jun; Moon, Sung K; Lee, Haa-Yung et al. (2008) Lysozyme M deficiency leads to an increased susceptibility to Streptococcus pneumoniae-induced otitis media. BMC Infect Dis 8:134
Lee, Haa-Yung; Takeshita, Tamotsu; Shimada, Jun et al. (2008) Induction of beta defensin 2 by NTHi requires TLR2 mediated MyD88 and IRAK-TRAF6-p38MAPK signaling pathway in human middle ear epithelial cells. BMC Infect Dis 8:87

Showing the most recent 10 out of 17 publications